Activity Reports

The fastest way to see what we re doing

Activity Report 2025 - part 1

(...) We have appreciated your interest in being more frequently informed about our activities, and it is with pleasure that we send you this activity report covering the first part of the year 2025.

Despite the difficulties caused by the current geopolitical situation and its repercussions on nuclear medicine and on our industry, we wanted to stay positive and move forward with projects and initiatives involving third parties. You will find them summarised below. (...)

Click to read part 1 of the Nuclear Medicine Europe Activity Report 2025

Activity Report 2024

(...) As we just completed the year 2024, the Chinese wisdom that “nearing completion” indicates there is still much to be done is particularly apt.
Taking the pen to write the greetings for the annual news is always an exciting moment. Being an active part in this vibrant field of today’s medicine is thrilling and challenging at the same time. We look back and realize the number of events, activities which were accomplished and the important decisions taken. (...)

Click to read the Nuclear Medicine Europe Activity Report 2024

Activity Report 2022

(...) These are turbulent times with the remnants of a pandemic, a war in Eastern Europe all causing besides actual pain also supply chain issues that influence our daily life and work environment.

But at the same time, Nuclear Medicine is making great strides towards a bright future with new theranostics coming up, an increasing recognition with referring physicians and regulators like EMA and European Institutions asking us for advice and collaboration. (...)

Click to read the Nuclear Medicine Europe Activity Report 2022

Activity Report 2020

Dear members of the NMEU General Assembly,
Dear friends and colleagues,

It is hard to talk about the year 2020 without dwelling too much on the coronavirus. We all know how last year was dominated by a once-in-a-century pandemic. Nonetheless, we kept our focus on our work and on offering patients access to nuclear medicine procedures. So, our story is about what we did to support the nuclear medicine sector.

(...)

This newsletter will not be like those of previous years. It will not show you meetings and social events that we would otherwise organise all over Europe and the United States.

Read the interactive activity report 2020

A nuclear medicine milestone

AIPES celebrates its 30th birthday in 2019

The date was May 5, 1989. That was when three radiopharmaceutical producers met to talk about the legal issues concerning the growing field of nuclear medicine. Their encounter 30 years ago marks the origin of our association. Today AIPES boasts more than 40 companies - from multinationals to SMEs - and our association is recognized around the world as the platform of the nuclear medicine industry in Europe.

Over the years we have managed various challenges, promoted innovation and delivered results. We aim to ensure that our products and practices are updated as new techniques and technologies emerge. We encourage dialogue: many nuclear medicine pioneers are still on board at AIPES, working with the newer players in the world of imaging.

As we approach our 30th anniversary, which we will celebrate at our next General Assembly meeting in May 2019, we realize that we still have a long way to go. But we are ready for the journey, with new projects, new ideas and your invaluable support. Once again, we would like to express how much your trust and confidence motivates us to go even further.

You did it again this year!

As the year draws to a close, we are delighted to report that it has been one of remarkable success. It is down to you: all of you who took part in the General Assembly, who led and contributed in the working groups, who are colleagues and friends of the AIPES community. Once again, you gave us your support, your confidence and your time.

It is an honor and a pleasure for us at the executive committee for the past 18 months to represent you all. We are proud to reflect your wishes, to give nuclear medicine the place it deserves in European healthcare, at the EU institution level, and to work together on behalf of patients. Halfway through our triennium, we are aware that our work would not be possible without your involvement. We look forward to continuing our mandate in the same spirit of partnership and co-operation.

Nuclear Medicine Europe